glp 1 drugs uk One in ten British adults used or interested in GLP-1 medications for weight loss Half the people in UK

10.3390/ijms18081649 25

The drugs, also commonly known as glucagon-like peptide 1 (GLP-1) receptor agonists or GLP-1 analogues, are normally prescribed for patients who have not been able to control their condition with tablet medication

Oxidative stress and neuroinflammation have been identified as key factors in the development of neurodegenerative diseases and are recognized as crucial targets for treatment [4]

They are a major defence system in deactivating toxic materials (as parent compounds or metabolites) via glutathione conjugation within the body [1]

Sugar D-ribose/nucleotides (uracil adenosine monophosphate) and peptide glutathione are demonstrated to have the similar potentiation through sensitizing aminoglycosides and meropenem, respectively 45,46,47,48